Skip to main content
SpringerLink
Log in
Book cover

Redo Cardiac Surgery in Adults pp 195–200Cite as

Percutaneous Approaches to Valvular Heart Disease After Previous Cardiac Surgery

  • Chapter
  • First Online:

  • 1038 Accesses

Abstract

While open surgical correction is the best treatment for most patients with valvular heart disease, there have been recent technical advances that permit percutaneous approaches to valve replacement and valve repair in selected circumstances. The most widely accepted catheter-based therapy for valvular heart disease is percutaneous balloon dilatation for rheumatic mitral valve stenosis, and this might be applicable to some patients who require relief of mitral valve stenosis after previous aortic or tricuspid valve surgery. As discussed earlier, degenerative mitral valve disease is the most common mitral valve etiology in Western populations, and considerable effort has been extended toward catheter-based methods for repair of mitral valve prolapse. Patients with aortic valve stenosis constitute the largest population of patients who might be considered for transcatheter therapy. Percutaneous and transapical insertion of collapsible bioprostheses has been used widely in elderly high-risk patients, and many of these patients have had previous cardiac surgery [1, 2].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Iung B. Management of the elderly patient with aortic stenosis. Heart. 2008;94:519–24.

    Article  PubMed  Google Scholar 

  2. Block PC. Percutaneous transcatheter repair for mitral regurgitation. J Interv Cardiol. 2006;19:547–51.

    Article  PubMed  Google Scholar 

  3. Klaabarg K-E, Egeblad H, Jakobsen C-J, et al. Transapical transcatheter treatment of a stenosed aortic valve bioprosthesis using the Edwards SAPIEN transcatheter heart valve. Ann Thorac Surg. 2009;87:1934–6.

    Article  Google Scholar 

  4. Hoffmayer KS, Zellner C, Kwan DM, et al. Closure of a para-valvular aortic leak: with the use of 2 AMPLATZER devices and real-time 2- and 3-dimensional transesophageal echocardiography. Tex Heart Inst J. 2011;38(1):81–4.

    PubMed  Google Scholar 

  5. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis. Circulation. 2002;106:3006–8.

    Article  PubMed  Google Scholar 

  6. Walther T, Chu MWA, Mohr W. Transcatheter aortic valve implantation: time to expand? Curr Opin Cardiol. 2008;23:111–6.

    Article  PubMed  Google Scholar 

  7. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2066;47:1214–23.

    Article  Google Scholar 

  8. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high risk patients with aortic valve disease. The Siegburg first-in-man study. Circulation. 2006;114:1616–24.

    Article  PubMed  Google Scholar 

  9. Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114(6):591–6.

    Article  PubMed  Google Scholar 

  10. Gruge E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high risk patients using the second- and current third-generation self-expanding CoreValve prosthesis. Device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69–76.

    Article  Google Scholar 

  11. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755–63.

    Article  PubMed  Google Scholar 

  12. Walther T, Falk V, Borger MA, et al. Minimally invasive transapical beating heart aortic valve implantation – proof of concept. Eur J Cardiothorac Surg. 2007;31:9–15.

    Article  PubMed  Google Scholar 

  13. Walter T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation. 2007;116(11 Suppl):I240–5.

    Google Scholar 

  14. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving system: results from the ­multicenter, expanded evaluation registry 1-year ­following CE mark approval. EuroIntervention. 2008;4:242–9.

    Article  PubMed  Google Scholar 

  15. Walther T, Falk V, Borger MA, et al. Transapical ­aortic valve implantation in patients requiring redo surgery. Eur J Cardiothorac Surg. 2009;36(2):231–4.

    Article  PubMed  Google Scholar 

  16. Dore A, Glancy DL, Stone S, Menashe VD, Somerville J. Cardiac surgery for grown-up congenital heart patients: survey of 307 consecutive operations from 1991 to 1994. Am J Cardiol. 1997;80:906–13.

    Article  PubMed  CAS  Google Scholar 

  17. Perloff JK, Natterson PD. Atrial arrhythmias in adults after repair of tetralogy of Fallot. Ann Thorac Surg. 1995;91:2118–9.

    CAS  Google Scholar 

  18. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 Guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008;118:2395–451.

    Article  PubMed  Google Scholar 

  19. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right ventricle to pulmonary artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–5.

    Article  PubMed  CAS  Google Scholar 

  20. Bonhoeffer P, Doudjemline Qureshi SA, et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol. 2002;39:1664–9.

    Article  PubMed  Google Scholar 

  21. McElhinney DB, Hellebrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US Melody valve trial. Circulation. 2010;122:507–16.

    Article  PubMed  Google Scholar 

  22. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122:674–81.

    Article  PubMed  CAS  Google Scholar 

  23. Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system. Safety and Midterm Durability in the Initial EVEREST (Endovascular Valve Edge-to-Edge REpair STudy) cohort. J Am Coll Cardiol. 2009;54:686–94.

    Article  PubMed  Google Scholar 

  24. Feldman T, Foster E, Glower DG, et al. Percutaneous repair of surgery for mitral regurgitation. N Engl J Med. 2011;364:1395–406.

    Article  PubMed  CAS  Google Scholar 

  25. Franzen O, Baldus S, Rudolph V, et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J. 2010;31:1373–81.

    Article  PubMed  Google Scholar 

  26. Tamburino C, Ussia GP, Maisano F, et al. Percutaneous mitral repair with the MitraClip system: acute results from a real world setting. Eur Heart J. 2010;31:1382–9.

    Article  PubMed  CAS  Google Scholar 

  27. Lim DS, Kunjummen BJ, Smailing R. Mitral valve repair with the MitraClip device after prior surgical mitral annuloplasty. Catheter Cardiovasc Interv. 2010;76:455–9.

    Article  PubMed  Google Scholar 

  28. Duffy SJ, Federman J, Farrington C, Reuter DG, Richardson M, Kaye DM. Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of functional mitral regurgitation in patients with heart failure. Catheter Cardiovasc Interv. 2006;68(2):205–10.

    Article  PubMed  Google Scholar 

  29. Gewillig M, Dubois C. Percutaneous Re-Revalvulation of the tricuspid valve. Catheter Cardiovasc Interv. 2011;77:692–5.

    Article  Google Scholar 

  30. Franzen O, von Samson P, Dodge-Khatami A, Geffert G, Baldus S. Percutaneous edge-to-edge repair of tricuspid regurgitation in congenitally corrected transposition of the great arteries. Congenit Heart Dis. 2011;6(1):57–9.

    Article  PubMed  Google Scholar 

  31. Sorajja P, Cabalka AK, Hagler DJ, et al. Successful percutaneous repair of perivalvular prosthetic regurgitation. Catheter Cardiovasc Interv. 2007;70:815–23.

    Article  PubMed  Google Scholar 

  32. De Cicco G, Russo C, Moreo AN, et al. Mitral valve periprosthetic leakage: anatomical observations in 135 patients from a multicentre study. Eur J Cardiothorac Surg. 2006;30:887–91.

    Article  PubMed  Google Scholar 

  33. Vassiliades Jr TA, Block PC, Cohn LH, et al. The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA). J Am Coll Cardiol. 2005;45:1554–60.

    Article  PubMed  Google Scholar 

  34. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187–2198.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA

    John M. Stulak MD & Hartzell V. Schaff MD

Authors
  1. John M. Stulak MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hartzell V. Schaff MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John M. Stulak MD .

Editor information

Editors and Affiliations

  1. Centre Ave 5200, Pittsburgh, 15232-1300, Pennsylvania, USA

    V.R. Machiraju

  2. , Division of Cardiovascular Surgery, Mayo Clinic, First Street SW 200, Rochester, 55905, Minnesota, USA

    Hartzell V. Schaff

  3. , Department of Thoracic and Cardiovascula, Cleveland Clinic Foundation, Euclid Avenue 9500, Cleveland, 44195, Ohio, USA

    Lars G. Svensson

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Stulak, J.M., Schaff, H.V. (2012). Percutaneous Approaches to Valvular Heart Disease After Previous Cardiac Surgery. In: Machiraju, V., Schaff, H., Svensson, L. (eds) Redo Cardiac Surgery in Adults. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1326-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-1326-4_21

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-1325-7

  • Online ISBN: 978-1-4614-1326-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation